These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope? Mamdani H; Jalal SI Front Cell Dev Biol; 2020; 8():582370. PubMed ID: 33163495 [TBL] [Abstract][Full Text] [Related]
3. The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy. Li G; Tian Y; Zhu WG Front Cell Dev Biol; 2020; 8():576946. PubMed ID: 33117804 [TBL] [Abstract][Full Text] [Related]
4. Prospects: histone deacetylase inhibitors. Dokmanovic M; Marks PA J Cell Biochem; 2005 Oct; 96(2):293-304. PubMed ID: 16088937 [TBL] [Abstract][Full Text] [Related]
5. Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy. Verza FA; Das U; Fachin AL; Dimmock JR; Marins M Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32585896 [TBL] [Abstract][Full Text] [Related]
6. Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease. Kulka LAM; Fangmann PV; Panfilova D; Olzscha H Front Cell Dev Biol; 2020; 8():425. PubMed ID: 32582706 [TBL] [Abstract][Full Text] [Related]
7. Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma. Phimmachanh M; Han JZR; O'Donnell YEI; Latham SL; Croucher DR Front Cell Dev Biol; 2020; 8():578770. PubMed ID: 33117806 [TBL] [Abstract][Full Text] [Related]
8. Targeting Histone Deacetylases in Diseases: Where Are We? Benedetti R; Conte M; Altucci L Antioxid Redox Signal; 2015 Jul; 23(1):99-126. PubMed ID: 24382114 [TBL] [Abstract][Full Text] [Related]
9. Epigenetic therapy of cancer with histone deacetylase inhibitors. Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells. Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133 [TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase modulators provided by Mother Nature. Seidel C; Schnekenburger M; Dicato M; Diederich M Genes Nutr; 2012 Jul; 7(3):357-67. PubMed ID: 22328271 [TBL] [Abstract][Full Text] [Related]
12. Targeting Histone Deacetylases in Malignant Melanoma: A Future Therapeutic Agent or Just Great Expectations? Garmpis N; Damaskos C; Garmpi A; Dimitroulis D; Spartalis E; Margonis GA; Schizas D; Deskou I; Doula C; Magkouti E; Andreatos N; Antoniou EA; Nonni A; Kontzoglou K; Mantas D Anticancer Res; 2017 Oct; 37(10):5355-5362. PubMed ID: 28982843 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53. Mrakovcic M; Bohner L; Hanisch M; Fröhlich LF Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544838 [TBL] [Abstract][Full Text] [Related]
18. From natural products to HDAC inhibitors: An overview of drug discovery and design strategy. Qiu X; Zhu L; Wang H; Tan Y; Yang Z; Yang L; Wan L Bioorg Med Chem; 2021 Dec; 52():116510. PubMed ID: 34826681 [TBL] [Abstract][Full Text] [Related]